So-called “poo transplants” have reached an important milestone with the publication of a new UK guideline that recognises their effectiveness at treating some persistent gut infections.
The National Institute for Health and Care Excellence (Nice) published its recommendation this week saying that the treatment, called faecal microbiota transplantation or FMT, should be used to treat recurrent infections of Clostridium difficile (C diff).
Nice found FMT to be an effective, safe and cost-effective treatment for adults who have had two or more C diff infections that have not responded to antibiotics.
